Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

Clinical trial NCT00338728 · COMPLETED

Trial details

NCT number: NCT00338728
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Estrogen Receptor Positive KIT Positive PDGFR Positive Postmenopausal Progesterone Receptor Positive Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2003-10-03
Primary completion: 2018-11-27
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.